FOLH1 and prostate carcinoma: Prostate specific radiotracers that bind to prostate-specific membrane antigen (PSMA), a type II transmembrane glycoprotein strongly overexpressed in prostate cancer cells, have revolutionised prostate cancer imaging and diagnosis.